Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Allen-Philbey, Kimberley
36  Ergebnisse:
Personensuche X
?
1

Parakinesia Brachialis Oscitans in a Patient With a First M..:

Salavisa, Manuel ; Mohamed, Bader ; Allen-Philbey, Kimberley...
Neurology Clinical Practice.  13 (2023)  6 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
2

Disease activity 4.5 years after starting cladribine: exper..:

Allen-Philbey, Kimberley ; De Trane, Stefania ; MacDougall, Amy...
Therapeutic Advances in Neurological Disorders.  16 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
3

Factors contributing to CSF NfL reduction over time in thos..:

Smets, Ide ; Holden, David ; Bianchi, Lucia...
Multiple Sclerosis and Related Disorders.  57 (2022)  - p. 103409 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Neuropsychological evaluation and rehabilitation in multipl..:

Topcu, Gogem ; Smith, Laura ; Mhizha-Murira, Jacqueline R....
Pilot and Feasibility Studies.  8 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
5

Disease activity after cladribine immune reconstitution the..:

Allen-Philbey, Kimberley ; Marta, Monica ; Gnanapavan, Sharmilee..
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
6

Evaluation of remote assessments for multiple sclerosis in ..:

Kuri, Ashvin ; Jacobs, Benjamin Meir ; Leddy, Sara...
Multiple Sclerosis and Related Disorders.  54 (2021)  - p. 103125 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Cladribine personalised dosing for active multiple sclerosi..:

Allen-Philbey, Kimberley ; De Trane, Stefania ; Stennett, Andrea...
Neurology.  96 (2021)  15_supplement - p. , 2021
Link: https://doi.org/10.1212/..
 
?
8

Subcutaneous cladribine to treat multiple sclerosis: experi..:

Allen-Philbey, Kimberley ; De Trane, Stefania ; Mao, Zhifeng...
Therapeutic Advances in Neurological Disorders.  14 (2021)  - p. 175628642110576 , 2021
Link: https://doi.org/10.1177/..
 
?
9

Socioeconomic status and disease-modifying therapy prescrib..:

Reyes, Saúl ; Suarez, Sebastian ; Allen-Philbey, Kimberley...
Multiple Sclerosis and Related Disorders.  41 (2020)  - p. 102024 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Can We Improve the Monitoring of People With Multiple Scler..:

Allen-Philbey, Kimberley ; Middleton, Rod ; Tuite-Dalton, Katie...
Frontiers in Neurology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
11

Postprandial Somnolence in People with Multiple Sclerosis (..:

Christmas, Tatiana ; Reyes, Saul ; Singh, Neena..
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
12

The Impact of Social Capital on Patients with Multiple Scle..:

Reyes, Saúl ; Suarez, Sebastian ; Allen-Philbey, Kimberley..
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
13

Treating the ineligible: Disease modification in people wit..:

Mao, Zhifeng ; Álvarez-González, César ; Allen-Philbey, Kimberley...
Multiple Sclerosis and Related Disorders.  27 (2019)  - p. 247-253 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Cladribine to treat Relapsing and Progressive Multiple Scle..:

De Trane, Stefania ; Mao, Zhifeng ; Alvarez-Gonzalez, Cesar...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
15

Personalised dosing of cladribine for people with multiple ..:

Mao, Zhifeng ; Alvarez-Gonzalez, Cesar ; Yildiz, Ozlem...
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
1-15